The iTind™ procedure is a safe and effective treatment for symptoms of enlarged prostate (BPH) in men aged 50 and older who have not found relief with prescription medications but are not yet ready for surgical treatment options.^1,2 The temporary implant reshapes the prostatic urethra to allow for better urine flow. The procedure can be done in your Urologist’s office, and most patients go home without a catheter.^1

Implantation of the iTind device may cause pelvic discomfort, blood in urine, painful or urgent urination. In rare cases, the iTind device may cause urinary tract infection or a sudden difficulty to urinate.

1. Amparore D, Fiori C, Valerio M, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2021.
2. Chughtai B, Elterman D, Shore N, et al. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial. Urology. 2020.



Follow us on social media! LinkedIn: https://www.linkedin.com/showcase/oly...
Twitter: https://twitter.com/OlympusMedUS
Facebook: https://www.facebook.com/olympusmedic...

Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies. Our Medical Business works with health care professionals to combine our innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing with their skills to deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes, reduce overall costs and enhance quality of life for patients. For more information, visit https://medical.olympusamerica.com.